Postoperative results after iris reconstruction with an Artificialiris

TRAUMA genetic/developmental defects < LENS/CATARACT intraoperative complications of cataract surgery < LENS/CATARACT surgical trauma < CORNEA/EXTERNAL DISEASE wound construction < LENS/CATARACT

Journal

European journal of ophthalmology
ISSN: 1724-6016
Titre abrégé: Eur J Ophthalmol
Pays: United States
ID NLM: 9110772

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 31 8 2023
pubmed: 15 2 2023
entrez: 14 2 2023
Statut: ppublish

Résumé

To test the hypothesis that severely damaged eyes are more likely to experience postoperative complications after an ArtificialIris Patients after iris reconstruction with an AI were included in this consecutive case series of the Department of Ophthalmology, University of Mainz, Germany. Best-corrected visual acuity (BCVA), objective refraction (KR 8900 Topcon, Tokyo, Japan) and Scheimpflug imaging of the anterior segment with Pentacam Thirty-two eyes of 32 patients after AI implantation were included, separated in partial or total aniridia in a closed globe (group 1, n = 16) and after perforating globe injury (group 2, n = 16). Two or more previous surgeries in the corresponding eye were found in two patients (12.5%) in group 1 and eleven patients (69%) in group 2 (p = 0.001). The time span between initial trauma or iris defect and AI implantation was not significantly related to the occurrence and severity of postoperative complications ( AI implantation is a treatment option for various iris defects. An individual, case-based decision should be made with strict indication also considering other possible methods for pupil reconstruction. The postoperative outcome is not affected by the time point of AI implantation. So, an implantation is already possible as early as six weeks after the previous trauma.

Identifiants

pubmed: 36788137
doi: 10.1177/11206721231156204
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1946-1951

Auteurs

Jana C Riedl (JC)

Department of Ophthalmology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.

Nora Pfeffer (N)

Department of Ophthalmology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.

Bert C Giers (BC)

Department of Ophthalmology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.

Alexander K Schuster (AK)

Department of Ophthalmology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.

Urs Vossmerbaeumer (U)

Department of Ophthalmology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH